95 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
German language Session
Q&A Modul
87
SCIENTIFIC PROGRAMME
S-025
Symposium
10:00– 11:30
|
Hall Helsinki 1
TOPIC 20:
Prevention and health promotion
Positive psychiatry: from mental illness to mental
health
Chairs:
Wolfgang Maier, Germany
Michaela Amering, Austria
001
Concepts and interventions in positive psychiatry
Martin Bohus, Germany
002
Recovery in mental health: reshaping responsi-
bilities
Michaela Amering, Austria
003
Successful aging
Wolfgang Maier, Germany
004
An epigenetic signature of resilience?
Bart Rutten, The Netherlands
S-026
Symposium
10:00– 11:30
|
Hall Helsinki 2
TOPIC 3:
Psychotic disorders
Limbic encephalitis and immunological encephalop-
athy: a revolutionary concept for psychiatry?
›
DGPPN Section: Neuropsychiatry
Chairs:
Ludger Tebartz van Elst, Germany
Josef Priller, Germany
001
Latest insights into the function of the CNS
immune system
Josef Priller, Germany
002
NMDA receptor encephalitis and other antibody
– mediated disorders of the synapse
Josep Dalmau, Spain
003
Antibody findings in psychiatric patients:
a critical analysis of the state-of-the-art
Angela Vincent, United Kingdom
004
Immunological encephalopathies in psychiatry:
clinical findings and therapeutic implications
Ludger Tebartz van Elst, Germany
S-027
Symposium
10:00– 11:30
|
Hall Paris 1
TOPIC 9:
Comorbidity of somatic and mental disorders,
psychosomatics
Increased morbidity and mortality among patients
with severe mental illness
Chairs:
Frank Schneider, Germany
Reinhard Heun, United Kingdom
001
Physical comorbidity and its relevance on
mortality in schizophrenia: a naturalistic 12-year
follow-up in general hospital admissions
Reinhard Heun, United Kingdom
002
Effects of antipsychotics, antidepressants and
mood stabilizers on risk for physical diseases in
people with severe mental illness
Christoph Correll, USA
003
Excess deaths and mortality trends in cardio-
vascular causes of deaths in schizophrenia, bipolar
and unipolar mood disorder in Sweden 1987–2010
Urban Ösby, Sweden
004
Mortality in severe mental illness: first time
results from statutory health insurance in Germany
Frank Schneider, Germany
Michael Erhart, Walter Hewer, Jessica Junger
S-028
Symposium
10:00– 11:30
|
Hall Paris 2
TOPIC 16:
Diagnostics and classification,
psychopathology, RDoC
Motor dysfunction in schizophrenia-spectrum dis-
orders and beyond: advances, challenges and future
directions
Chairs:
Dusan Hirjak, Germany
Robert Christian Wolf, Germany
001
Does subtle motor dysfunction in healthy indi-
viduals represent a biomarker of vulnerability
to psychosis?
Dusan Hirjak, Germany
002
Motor dysfunction and motion energy analysis
in ultra-high risk individuals as biomarkers of
progression to psychosis
Tina Gupta, USA
003
Aberrant functional connectivity within the
motor system is linked to motor abnormalities in
psychosis
Sebastian Walther, Switzerland
Andrea Federspiel, Katharina Stegmayer, Petra Viher
004
Beyond schizophrenia: transnosologic aspects
of motor dysfunction
Robert Christian Wolf, Germany